6
Views
2
CrossRef citations to date
0
Altmetric
Review

Selected topics in pediatric hair loss

, , , &
Pages 795-804 | Published online: 10 Jan 2014

References

  • Hwang SM, Lee WS, Choi EH, Lee SH, Ahn SK. Nurse’s cap alopecia. Int. J. Dermatol.38(3), 187–191 (1999).
  • Sperling LC, Lupton GP. Histopathology of non-scarring alopecia. J. Cutan. Pathol.22(2), 97–114 (1995).
  • Trueb RM. ‘Chignon alopecia’: a distinctive type of nonmarginal traction alopecia. Cutis55(3), 178–179 (1995).
  • Whiting DA. Traumatic alopecia. Int. J. Dermatol.38(Suppl. 1), 34–44 (1999).
  • Hjorth N. Traumatic marginal alopecia; a special type: alopecia groenlandica. Br. J. Dermatol.69(9), 319–322 (1957).
  • Rollins TG. Traction follicultis with hair casts and alopecia. Am. J. Dis. Child.101, 639–640 (1961).
  • Slepyan AH. Traction alopecia. AMA Arch. Derm.78(3), 395–398 (1958).
  • Brunner MJ, Facq JM. A pseudoparasite of the scalp hair. AMA Arch. Derm.75(4), 583 (1957).
  • Keipert JA. Hair casts. Review and suggestion regarding nomenclature. Arch. Dermatol.122(8), 927–930 (1986).
  • Wilborn W. Disorders of hair growth in African–Americans. In: Disorders of Hair Growth Diagnosis and Treatment. Olsen E (Ed.). McGraw–Hill, NY, USA, 389–407 (1994).
  • Hantash BM, Schwartz RA. Traction alopecia in children. Cutis71(1), 18–20 (2003).
  • Scott DA. Disorders of the hair and scalp in blacks. Dermatol. Clin.6(3), 387–395 (1988).
  • Spencer GA. Alopecia luminaris frontalis. Arch. Dermatol. Syphilol.44, 1082–1085 (1941).
  • Costa OC. Traumatic negroid alopecia. Br. J. Dermatol.58, 280–282 (1946).
  • Sperling LC, Mezebish DS. Hair diseases. Med. Clin. North Am.82(5), 1155–1169 (1998).
  • Sabouraud R. De l’alopécie liminaire frontale. Ann. Dermatol. Syphiligr.2, 446 (1931).
  • Rudolph RI, Klein AW, Decherd JW. Corn-row alopecia. Arch. Dermatol.108(1), 134 (1973).
  • Morgan HV. Traction alopecia. Br. Med. J.2(5192), 115–117 (1960).
  • Gormley TP, Sokoll MD. Permanent alopecia from pressure of a head strap. JAMA199(10), 747–748 (1967).
  • Harman RR. Traction alopecia due to ‘hair extension’. Br. J. Dermatol.87(1), 79–80 (1972).
  • Kanwar AJ, Kaur S, Basak P, Sharma R. Traction alopecia in Sikh males. Arch. Dermatol.125(11), 1587 (1989).
  • Singh G. Letter: Traction alopecia in Sikh boys. Br. J. Dermatol.92(2), 232–233 (1975).
  • Khumalo NP, Jessop S, Gumedze F, Ehrlich R. Hairdressing is associated with scalp disease in African schoolchildren. Br. J. Dermatol.(2007).
  • Ayres S Jr., Ayres S III, Mirovich JI. Traumatic marginal alopecia in white women. Arch. Dermatol. Syphilol.60(6), 1116–1119 (1949).
  • Lipnik MJ. Traumatic alopecia from brush rollers. Arch. Dermatol.84, 493–495 (1961).
  • Ikeda T, Yamada M. Factors in telogen affluvium and traction alopecia. Acta Dermatol. Kyoto Engl. Ed.62(2), 109–113 (1967).
  • Callender VD, McMichael AJ, Cohen GF. Medical and surgical therapies for alopecias in black women. Dermatol. Ther.17(2), 164–176 (2004).
  • McMichael AJ. Scalp and hair disease in the black patient. In: Ethnic Skin: Medical and Surgical. Johnson BL, Moy RL, White GM (Eds). Mosby, MO, USA 214–230 (1998).
  • Khumalo NP, Ngwanya RM. Traction alopecia: 2% topical minoxidil shows promise. Report of two cases. J. Eur. Acad. Dermatol. Venereol.21(3), 433–434 (2007).
  • Earles RM. Surgical correction of traumatic alopecia marginalis or traction alopecia in black women. J. Dermatol. Surg. Oncol.12(1), 78–82 (1986).
  • Kolasinski J, Kolenda M. Algorithm of hair restoration surgery in children. Plast. Reconstr. Surg.112(2), 412–422 (2003).
  • Ozcelik D. Extensive traction alopecia attributable to ponytail hairstyle and its treatment with hair transplantation. Aesthetic Plast. Surg.29(4), 325–327 (2005).
  • Ghannoum M, Isham N, Hajjeh R et al. Tinea capitis in Cleveland: survey of elementary school students. J. Am. Acad. Dermatol.48(2), 189–193 (2003).
  • Alvarez MS, Silverberg NB. Tinea capitis. Cutis78(3), 189–196 (2006).
  • Sterling JB, Sina B, Gaspari A, Deng A. Acne keloidalis: a novel presentation for tinea capitis. J. Am. Acad. Dermatol.56(4), 699–701 (2007).
  • Elewski BE. Tinea capitis: a current perspective. J. Am. Acad. Dermatol.42(1 Pt 1), 1–20 (2000).
  • Foster KW, Friedlander SF, Panzer H, Ghannoum MA, Elewski BE. A randomized controlled trial assessing the efficacy of fluconazole in the treatment of pediatric tinea capitis. J. Am. Acad. Dermatol.53(5), 798–809 (2005).
  • Ghannoum MA, Elewski B. Etiology of tinea capitis in the United States and Puerto Rico, Latin America and Mexico, and India. J. Am. Acad. Dermatol.50, 100 (2004).
  • Higgins EM, Fuller LC, Smith CH. Guidelines for the management of tinea capitis. British Association of Dermatologists. Br. J. Dermatol.143(1), 53–58 (2000).
  • Tanz RR, Hebert AA, Esterly NB. Treating tinea capitis: should ketoconazole replace griseofulvin? J. Pediatr.112(6), 987–991 (1988).
  • Chen BK, Friedlander SF. Tinea capitis update: a continuing conflict with an old adversary. Curr. Opin Pediatr.13(4), 331–335 (2001).
  • Bennett ML, Fleischer AB, Loveless JW, Feldman SR. Oral griseofulvin remains the treatment of choice for tinea capitis in children. Pediatr. Dermatol.17(4), 304–309 (2000).
  • Chan YC, Friedlander SF. Therapeutic options in the treatment of tinea capitis. Expert Opin. Pharmacother.5(2), 219–227 (2004).
  • Ginter-Hanselmayer G, Smolle J, Gupta A. Itraconazole in the treatment of tinea capitis caused by Microsporum canis: experience in a large cohort. Pediatr. Dermatol.21(4), 499–502 (2004).
  • Gupta AK, Adam P, Dlova N et al. Therapeutic options for the treatment of tinea capitis caused by Trichophyton species: griseofulvin versus the new oral antifungal agents, terbinafine, itraconazole, and fluconazole. Pediatr. Dermatol.18(5), 433–438 (2001).
  • Lopez-Gomez S, Del Palacio A, Van Cutsem J, Soledad Cuetara M, Iglesias L, Rodriguez-Noriega A. Itraconazole versus griseofulvin in the treatment of tinea capitis: a double-blind randomized study in children. Int. J. Dermatol.33(10), 743–747 (1994).
  • Neil G, Hanslo D, Buccimazza S, Kibel M. Control of the carrier state of scalp dermatophytes. Pediatr. Infect. Dis. J.9(1), 57–58 (1990).
  • Roberts BJ, Friedlander SF. Tinea capitis: a treatment update. Pediatr. Ann.34(3), 191–200 (2005).
  • Zhang AY, Camp WL, Elewski BE. Advances in topical and systemic antifungals. Dermatol. Clin.25(2), 165–183 (2007).
  • Givens TG, Murray MM, Baker RC. Comparison of 1% and 2.5% selenium sulfide in the treatment of tinea capitis. Arch. Pediatr. Adolesc. Med.149(7), 808–811 (1995).
  • Greer DL. Successful treatment of tinea capitis with 2% ketoconazole shampoo. Int. J. Dermatol.39(4), 302–304 (2000).
  • Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ 3rd. Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin. Proc.70(7), 628–633 (1995).
  • Yang S, Yang J, Liu JB et al. The genetic epidemiology of alopecia areata in China. Br. J. Dermatol.151(1), 16–23 (2004).
  • Sharma VK, Kumar B, Dawn G. A clinical study of childhood alopecia areata in Chandigarh, India. Pediatr. Dermatol.13(5), 372–377 (1996).
  • Tan E, Tay YK, Goh CL, Chin Giam Y. The pattern and profile of alopecia areata in Singapore – a study of 219 Asians. Int. J. Dermatol.41(11), 748–753 (2002).
  • Nanda A, Al-Hasawi F, Alsaleh QA. A prospective survey of pediatric dermatology clinic patients in Kuwait: an analysis of 10,000 cases. Pediatr. Dermatol.16(1), 6–11 (1999).
  • Kurtev A, Iliev E. Thyroid autoimmunity in children and adolescents with alopecia areata. Int. J. Dermatol.44(6), 457–461 (2005).
  • Nanda A, Al-Fouzan AS, Al-Hasawi F. Alopecia areata in children: a clinical profile. Pediatr. Dermatol.19(6), 482–485 (2002).
  • McDonagh AJ, Snowden JA, Stierle C, Elliott K, Messenger AG. HLA and ICAMH1 expression in alopecia areata in vivo and in vitro: the role of cytokines. Br. J. Dermatol.129(3), 250–256 (1993).
  • Akar A, Orkunoglu E, Sengul A, Ozata M, Gur AR. HLA class II alleles in patients with alopecia areata. Eur. J. Dermatol.12(3), 236–239 (2002).
  • Colombe BW, Lou CD, Price VH. The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis. J. Investig. Dermatol. Symp. Proc.4(3), 216–219 (1999).
  • Colombe BW, Price VH, Khoury EL, Garovoy MR, Lou CD. HLA class II antigen associations help to define two types of alopecia areata. J. Am. Acad. Dermatol.33(5 Pt 1), 757–764 (1995).
  • Khoury EL, Price VH, Greenspan JS. HLA-DR expression by hair follicle keratinocytes in alopecia areata: evidence that it is secondary to the lymphoid infiltration. J. Invest. Dermatol.90(2), 193–200 (1988).
  • Messenger AG, Bleehen SS. Expression of HLA-DR by anagen hair follicles in alopecia areata. J. Invest. Dermatol.85, 569–572 (1985).
  • Todes-Taylor N, Turner R, Wood GS, Stratte PT, Morhenn VB. T cell subpopulations in alopecia areata. J. Am. Acad. Dermatol.11(2 Pt 1), 216–223 (1984).
  • Tobin DJ. Morphological analysis of hair follicles in alopecia areata. Microsc. Res. Tech.38(4), 443–451 (1997).
  • Tobin DJ, Hann SK, Song MS, Bystryn JC. Hair follicle structures targeted by antibodies in patients with alopecia areata. Arch. Dermatol.133(1), 57–61 (1997).
  • Illig R, Krawczynska H, Torresani T, Prader A. Elevated plasma TSH and hypothyroidism in children with hypothalamic hypopituitarism. J. Clin. Endocrinol. Metab.41(4), 722–728 (1975).
  • Milgraum SS, Mitchell AJ, Bacon GE, Rasmussen JE. Alopecia areata, endocrine function, and autoantibodies in patients 16 years of age or younger. J. Am. Acad. Dermatol.17(1), 57–61 (1987).
  • Shellow WV, Edwards JE, Koo JY. Profile of alopecia areata: a questionnaire analysis of patient and family. Int. J. Dermatol.31(3), 186–189 (1992).
  • Lacarrubba F, Dall’Oglio F, Rita Nasca M, Micali G. Videodermatoscopy enhances diagnostic capability in some forms of hair loss. Am. J. Clin. Dermatol.5(3), 205–208 (2004).
  • MacDonald Hull SP, Wood ML, Hutchinson PE, Sladden M, Messenger AG. Guidelines for the management of alopecia areata. Br. J. Dermatol.149(4), 692–699 (2003).
  • Madani S, Shapiro J. Alopecia areata update. J. Am. Acad. Dermatol.42(4), 549–566 (2000).
  • LaRow JA, Mysliborski J, Rappaport IP, Rouleau GA, Carlson JA. Alopecia areata universalis in an infant. J. Cutan. Med. Surg.5(2), 131–134 (2001).
  • Ahmad W, Faiyaz ul Haque M, Brancolini V et al. Alopecia universalis associated with a mutation in the human hairless gene. Science279(5351), 720–724 (1998).
  • Marx SJ, Bliziotes MM, Nanes M. Analysis of the relation between alopecia and resistance to 1,25-dihydroxyvitamin D. Clin. Endocrinol. (Oxf.)25(4), 373–381 (1986).
  • Whiting D. The histopathology of alopecia areata in vertical and horizontal sections. Dermatol. Ther.14, 297–305 (2001).
  • Silverberg NB. Helping children cope with hair loss. Cutis78(5), 333–336 (2006).
  • Hull SM, Pepall L, Cunliffe WJ. Alopecia areata in children: response to treatment with diphencyprone. Br. J. Dermatol.125(2), 164–168 (1991).
  • Tosti A, Piraccini BM, Pazzaglia M, Vincenzi C. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis. J. Am. Acad. Dermatol.49(1), 96–98 (2003).
  • Price VH. Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata. J. Am. Acad. Dermatol.16(3 pt 2), 730–736 (1987).
  • Ranchoff RE, Bergfeld WF, Steck WD, Subichin SJ. Extensive alopecia areata. Results of treatment with 3% topical minoxidil. Cleve. Clin. J. Med.56(2), 149–154 (1989).
  • Kubeyinje EP. Intralesional triamcinolone acetonide in alopecia areata amongst 62 Saudi Arabs. East Afr. Med. J.71(10), 674–675 (1994).
  • Dall’oglio F, Nasca MR, Musumeci ML et al. Topical immunomodulator therapy with squaric acid dibutylester (SADBE) is effective treatment for severe alopecia areata (AA), results of an open-label, paired-comparison, clinical trial. J. Dermatolog. Treat.16(1), 10–14 (2005).
  • Rokhsar CK, Shupack JL, Vafai JJ, Washenik K. Efficacy of topical sensitizers in the treatment of alopecia areata. J. Am. Acad. Dermatol.39(5 Pt 1), 751–761 (1998).
  • Happle R, Hausen BM, Wiesner-Menzel L. Diphencyprone in the treatment of alopecia areata. Acta Derm. Venereol.63(1), 49–52 (1983).
  • Brocker EB, John SM, Steinhausen D, Hamm H. Topical immunotherapy with contact allergens in alopecia areata: evidence for non-specific systemic suppression of cellular immune reactions. Arch. Dermatol. Res.283(2), 133–134 (1991).
  • Tsai YM, Chen W, Hsu ML, Lin TK. High-dose steroid pulse therapy for the treatment of severe alopecia areata. J. Formos. Med. Assoc.101(3), 223–226 (2002).
  • Fiedler-Weiss VC, Buys CM. Evaluation of anthralin in the treatment of alopecia areata. Arch. Dermatol.123(11), 1491–1493 (1987).
  • Nelson DA, Spielvogel RL. Anthralin therapy for alopecia areata. Int. J. Dermatol.24(9), 606–607 (1985).
  • Zakaria W, Passeron T, Ostovari N, Lacour JP, Ortonne JP. 308-nm excimer laser therapy in alopecia areata. J. Am. Acad. Dermatol.51(5), 837–838 (2004).
  • Price VH, Willey A, Chen BK. Topical tacrolimus in alopecia areata. J. Am. Acad. Dermatol.52(1), 138–139 (2005).
  • Claudy AL, Gagnaire D. PUVA treatment of alopecia areata. Arch. Dermatol.119(12), 975–978 (1983).
  • Lassus A, Eskelinen A, Johansson E. Treatment of alopecia areata with three different PUVA modalities. Photodermatol.1(3), 141–144 (1984).
  • van der Schaar WW, Sillevis Smith JH. An evaluation of PUVA-therapy for alopecia areata. Dermatologica168(5), 250–252 (1984).
  • Healy E, Rogers S. PUVA treatment for alopecia areata – does it work? A retrospective review of 102 cases. Br. J. Dermatol.129(1), 42–44 (1993).
  • Taylor CR, Hawk JL. PUVA treatment of alopecia areata partialis, totalis and universalis: audit of 10 years’ experience at St John’s Institute of Dermatology. Br. J. Dermatol.133(6), 914–918 (1995).
  • Holme SA, Anstey AV. Phototherapy and PUVA photochemotherapy in children. Photodermatol. Photoimmunol. Photomed.20(2), 69–75 (2004).
  • Sharquie KE, Al-Obaidi HK. Onion juice (Allium cepa L.), a new topical treatment for alopecia areata. J. Dermatol.29(6), 343–346 (2002).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.